Zoekresultaten - Jeffrey W. Clark

Verfijn jouw resultaten
  1. 1
    Headaches and Oral Contraceptives: Impact of Eliminating the Standard 7‐Day Placebo Interval

    Headaches and Oral Contraceptives: Impact of Eliminating the Standard 7‐Day Placebo Interval door Patricia J. Sulak, Sherilyn Willis, Thomas J. Kuehl, Andrea Coffee, Jeffrey W. Clark

    Gepubliceerd in 2007
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  2. 2
    Quality of Informed Consent: a New Measure of Understanding Among Research Subjects

    Quality of Informed Consent: a New Measure of Understanding Among Research Subjects door Steven Joffe, E. Francis Cook, Paul D. Cleary, Jeffrey W. Clark, Jane C. Weeks

    Gepubliceerd in 2001
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  3. 3
    Familial Gastric Cancers

    Familial Gastric Cancers door Namrata Setia, Jeffrey W. Clark, Dan G. Duda, Theodore S. Hong, Eunice L. Kwak, John T. Mullen, Gregory Y. Lauwers

    Gepubliceerd in 2015
    Volledige tekst Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  4. 4
    Gemcitabine‐associated thrombotic microangiopathy

    Gemcitabine‐associated thrombotic microangiopathy door Benjamin D. Humphreys, Jeff P. Sharman, Joel Henderson, Jeffrey W. Clark, Peter Marks, Helmut G. Rennke, Andrew X. Zhu, Colm Magee

    Gepubliceerd in 2004
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  5. 5
    Rapid Radiographic and Clinical Improvement After Treatment of a <i>MET</i>-Amplified Recurrent Glioblastoma With a Mesenchymal-Epithelial Transition Inhibitor

    Rapid Radiographic and Clinical Improvement After Treatment of a <i>MET</i>-Amplified Recurrent Glioblastoma With a Mesenchymal-Epithelial Transition Inhibitor door S. Andrew, Tracy T. Batchelor, Eunice L. Kwak, Jeffrey W. Clark, Daphne L. Wang, Keith D. Wilner, David N. Louis, A. John Iafrate

    Gepubliceerd in 2011
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  6. 6
    A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma

    A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma door Charles S. Fuchs, Jeffrey W. Clark, David P. Ryan, M. Kulke, Haesook Kim, Craig C. Earle, Michele Vincitore, Robert J. Mayer, Keith Stuart

    Gepubliceerd in 2002
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  7. 7
    Modes of transmission and evidence for viral latency from studies of human T-cell lymphotrophic virus type I in Japanese migrant populations in Hawaii.

    Modes of transmission and evidence for viral latency from studies of human T-cell lymphotrophic virus type I in Japanese migrant populations in Hawaii. door William A. Blattner, Abraham M. Y. Nomura, Jeffrey W. Clark, Gloria Y. F. Ho, Y Nakao, R C Gallo, Marjorie Robert-Guroff

    Gepubliceerd in 1986
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  8. 8
    A Phase II trial of gemcitabine for metastatic neuroendocrine tumors

    A Phase II trial of gemcitabine for metastatic neuroendocrine tumors door Matthew H. Kulke, Haesook Kim, Jeffrey W. Clark, Peter C. Enzinger, Thomas J. Lynch, Jeffrey A. Morgan, Michele Vincitore, Ann Michelini, Charles S. Fuchs

    Gepubliceerd in 2004
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  9. 9
    Phase II study of the multitargeted antifolate LY231514 (ALIMTA™, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer

    Phase II study of the multitargeted antifolate LY231514 (ALIMTA™, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer door Kathy D. Miller, Joel Picus, Charles D. Blanke, William J. John, Jeffrey W. Clark, Lawrence N. Shulman, D. Thornton, Eric K. Rowinsky, Patrick J. Loehrer

    Gepubliceerd in 2000
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  10. 10
    Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid Tumors

    Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid Tumors door Dirk Strumberg, Jeffrey W. Clark, Ahmad Awada, Malcolm J. Moore, Heike Richly, Alain Hendlisz, Hal W. Hirte, Joseph P. Eder, Heinz‐Josef Lenz, Brian Schwartz

    Gepubliceerd in 2007
    Volledige tekst Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  11. 11
    Seroepidemiologic Studies Of Human T‐cell leukemia/lymphoma virus type I in Jamaica

    Seroepidemiologic Studies Of Human T‐cell leukemia/lymphoma virus type I in Jamaica door Jeffrey W. Clark, Arthur Ensroth, William A. Blattner, Carl Saxinger, Marjorie Robert‐Guroff, Robert C. Gallo, W. N. Gibbs, W. Lofters, Lois Lagranade, K DeCeulaer

    Gepubliceerd in 1985
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  12. 12
    Capecitabine Plus Erlotinib in Gemcitabine-Refractory Advanced Pancreatic Cancer

    Capecitabine Plus Erlotinib in Gemcitabine-Refractory Advanced Pancreatic Cancer door Matthew H. Kulke, Lawrence S. Blaszkowsky, David P. Ryan, Jeffrey W. Clark, Jeffrey A. Meyerhardt, Andrew X. Zhu, Peter C. Enzinger, Eunice L. Kwak, Alona Muzikansky, Colleen Lawrence, Charles S. Fuchs

    Gepubliceerd in 2007
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  13. 13
    Phase II Study of Capecitabine, Oxaliplatin, and Erlotinib in Previously Treated Patients With Metastastic Colorectal Cancer

    Phase II Study of Capecitabine, Oxaliplatin, and Erlotinib in Previously Treated Patients With Metastastic Colorectal Cancer door Jeffrey A. Meyerhardt, Andrew X. Zhu, Peter C. Enzinger, David P. Ryan, Jeffrey W. Clark, Matthew H. Kulke, Craig C. Earle, Michele Vincitore, Ann Michelini, Susan Sheehan, Charles S. Fuchs

    Gepubliceerd in 2006
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  14. 14
    <i>O</i> 6-Methylguanine DNA Methyltransferase Deficiency and Response to Temozolomide-Based Therapy in Patients with Neuroendocrine Tumors

    <i>O</i> 6-Methylguanine DNA Methyltransferase Deficiency and Response to Temozolomide-Based Therapy in Patients with Neuroendocrine Tumors door Matthew H. Kulke, Jason L. Hornick, Christine Frauenhoffer, Susanne M. Hooshmand, David P. Ryan, Peter C. Enzinger, Jeffrey A. Meyerhardt, Jeffrey W. Clark, Keith Stuart, Charles S. Fuchs, Mark Redston

    Gepubliceerd in 2008
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  15. 15
    Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma

    Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma door Andrew X. Zhu, Keith Stuart, Lawrence S. Blaszkowsky, Alona Muzikansky, Donald P. Reitberg, Jeffrey W. Clark, Peter C. Enzinger, Pankaj Bhargava, Jeffrey A. Meyerhardt, Kerry Horgan, Charles S. Fuchs, David P. Ryan

    Gepubliceerd in 2007
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  16. 16
    Long-term Results of Intraoperative Electron Beam Irradiation (IOERT) for Patients With Unresectable Pancreatic Cancer

    Long-term Results of Intraoperative Electron Beam Irradiation (IOERT) for Patients With Unresectable Pancreatic Cancer door Christopher G. Willett, Carlos Fernández del Castillo, Helen A. Shih, Saveli Goldberg, Peter J. Biggs, Jeffrey W. Clark, Gregory Y. Lauwers, David P. Ryan, Andrew X. Zhu, Andrew L. Warshaw

    Gepubliceerd in 2005
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  17. 17
    Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC

    Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC door S.-H.I. Ou, Pasi A. Jänne, Cynthia Huang Bartlett, Yiyun Tang, D.-W. Kim, Gregory A. Otterson, Lucio Crinò, Paulina Selaru, D. P. Cohen, Jeffrey W. Clark, Gregory J. Riely

    Gepubliceerd in 2014
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  18. 18
    Acquired Resistance to Crizotinib in NSCLC with MET Exon 14 Skipping

    Acquired Resistance to Crizotinib in NSCLC with MET Exon 14 Skipping door Rebecca S. Heist, Lecia V. Sequist, Darrell R. Borger, Justin F. Gainor, Ronald S. Arellano, Long P. Le, Dora Dias‐Santagata, Jeffrey W. Clark, Jeffrey A. Engelman, Alice T. Shaw, A. John Iafrate

    Gepubliceerd in 2016
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  19. 19
    A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma

    A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma door David P. Ryan, Matthew H. Kulke, Charles S. Fuchs, Michael L. Grossbard, Steven R. Grossman, Jeffrey A. Morgan, Craig C. Earle, Ramesh A. Shivdasani, Haesook Kim, Robert J. Mayer, Jeffrey W. Clark

    Gepubliceerd in 2001
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  20. 20
    Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors

    Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors door Jennifer A. Chan, Keith Stuart, Craig C. Earle, Jeffrey W. Clark, Pankaj Bhargava, Rebecca A. Miksad, Lawrence S. Blaszkowsky, Peter C. Enzinger, Jeffrey A. Meyerhardt, Hui Zheng, Charles S. Fuchs, Matthew H. Kulke

    Gepubliceerd in 2012
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:

Zoekinstrumenten: